{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:28:10Z","timestamp":1736314090798,"version":"3.32.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00392-006-1121-0","type":"journal-article","created":{"date-parts":[[2006,1,23]],"date-time":"2006-01-23T12:52:22Z","timestamp":1138020742000},"page":"i48-i53","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes und Herztransplantation","Diabetes and heart transplantation"],"prefix":"10.1007","volume":"95","author":[{"given":"M.","family":"Loebe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ramasubbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1121_CR1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF02564867","volume":"30","author":"Aker","year":"1998","unstructured":"Aker S, Ivens K, Grabensee B et al (1998) Cardiovascular risk factors and diseases after renal transplantation. Int Urol Nephrol 30:777","journal-title":"Int Urol Nephrol"},{"key":"1121_CR2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2007-1012038","volume":"44","author":"Aleksic","year":"1996","unstructured":"Aleksic I, Czer LSC, Freimark D, Dalichau H, Takkenberg JJM, Blanche C, et al (1996) Heart transplantation in patients with diabetic endorgan damage before transplantation. Thorac Cardiovasc Surg 44:282\u2013288","journal-title":"Thorac Cardiovasc Surg"},{"key":"1121_CR3","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","volume":"283","author":"ALLHAT","year":"2000","unstructured":"ALLHAT collaborative research group (2000) JAMA 283:1967\u20131975","journal-title":"JAMA"},{"key":"1121_CR4","first-page":"2384","volume":"22","author":"Badellino","year":"1990","unstructured":"Badellino MM, Cavarocchi NC, Narins B, Jessup M, Alpern JB, McClurken JB et al (1990) Cardiac transplantation in diabetic patients. Transplant Proc 22:2384\u20132388","journal-title":"Transplant Proc"},{"key":"1121_CR5","first-page":"166","volume":"28","author":"Benhamou","year":"2002","unstructured":"Benhamou PY, Penfornis A (2002) Natural history, prognosis and management of transplantation-induced diabetes mellitus. Diabetes Metab 28:166","journal-title":"Diabetes Metab"},{"key":"1121_CR6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/00007890-200212270-00011","volume":"74","author":"Boots","year":"2002","unstructured":"Boots JMM, Christiaans MHL, van Duijnhoven EM, van Suylen RJ, van Hooff JP (2002) Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. Transplantation 74:1703\u20131709","journal-title":"Transplantation"},{"key":"1121_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1681\/ASN.V131221","volume":"13","author":"Boots","year":"2002","unstructured":"Boots JMM, van Duijnhoven EM, Christiaans MHL, Wolffenbuttel BHR, van Hooff JP (2002) Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 13:221\u2013227","journal-title":"J Am Soc Nephrol"},{"key":"1121_CR8","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s00125-002-0960-0","volume":"45","author":"Czerny","year":"2002","unstructured":"Czerny M, Sahin V, Fasching P, Zuckermann A, Zimpfer D, Kilo J, Wolner E, Grimm M (2002) The impact of diabetes mellitus at the time of heart transplantation on long-term survival. Diabetologia 45:1498\u20131508","journal-title":"Diabetologia"},{"key":"1121_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1464-5491.2000.00206.x","volume":"17","author":"Depcynski","year":"2000","unstructured":"Depcynski B, Daly B, Campbell LV, Chisholm DJ, Keogh A (2000) Predicting occurrence of diabetes mellitus in recipients of heart transplants. Diabet Med 17:15\u201319","journal-title":"Diabet Med"},{"key":"1121_CR10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00007890-199909150-00012","volume":"68","author":"Eisen","year":"1999","unstructured":"Eisen HJ, Hobbs RE, Davis SF, Laufer G, Mancini DM, Renlund DG, Valantine H, Ventura H, Vachiery JL, Bourge RC, Canver CC, Carrier M, Costanzo MR, Copeland J, Dureau G, Frazier OH, Dorent R, Hauptman PJ, Kells C, Master R, Michaud JL, Paradis I, Smith A, Vanh\u00e4cke J, M\u00fcller EA et al (1999) Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine: results at six months after transplantation. Transplantation 68:663\u2013671","journal-title":"Transplantation"},{"key":"1121_CR11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00007890-199307000-00013","volume":"56","author":"Ensley","year":"1993","unstructured":"Ensley RD, Bristow MR, Olsen SL, Taylor DO, Hammond EH, O\u2019Connell JB, Dunn D, Osburn L, Jones KW, Kauffman RS, Gay WA, Renlund DG (1993) The use of mycophenolate mofetil (RS-61443] in human heart transplant recipients. Transplantation 56:75\u201382","journal-title":"Transplantation"},{"key":"1121_CR12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","volume":"344","author":"European","year":"1994","unstructured":"European FK 506 multicentre study group (1994) Randomised trial comparing tacrolimus to cyclosporine in prevention of liver allograft rejection. Lancet 344:423\u2013428","journal-title":"Lancet"},{"key":"1121_CR13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/00007890-199311000-00017","volume":"56","author":"Fabian","year":"1993","unstructured":"Fabian MC, Lakey JRT, Rajotte RV, Kneteman NM (1993) The efficacy and toxicity of rapamycin in murine islet transplantation. Transplantation 56:1137\u20131142","journal-title":"Transplantation"},{"key":"1121_CR14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2337\/diab.39.6.740","volume":"39","author":"Faglia","year":"1990","unstructured":"Faglia E, Favales F, Mazzola E, Pizzi G, De Maria R, Mangiavacchi M et al (1990) Heart transplant in mildly diabetic patients. Diabetes 39:740\u2013742","journal-title":"Diabetes"},{"key":"1121_CR15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1053-2498(01)00417-X","volume":"21","author":"Felkel","year":"2002","unstructured":"Felkel TO, Smith AL, Reichenspurner HC, LaFleur B, Lutz JF, Kanter KR, Gravanis MB, Johnston TS (2002) Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy. J Heart Lung Transplant 21(5):530\u2013539","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1067\/mtc.2003.181","volume":"125","author":"Furnary","year":"2003","unstructured":"Furnary AP et al (2003) Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007\u20131021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1121_CR17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0735-1097(88)90402-0","volume":"12","author":"Gao","year":"1988","unstructured":"Gao SZ, Alderman EL, Schr\u00f6der JS, Silverman JF, Hunt SA (1988) Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 12:334\u2013340","journal-title":"J Am Coll Cardiol"},{"key":"1121_CR18","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00007890-199111000-00026","volume":"52","author":"Gillison","year":"1991","unstructured":"Gillison SL, Bartlett ST, Curry DL (1991) Inhibition by cyclosporine of insulin secretion\u2014A beta cell\u2013specific alteration of islet tissue function. Transplantation 52:890\u2013895","journal-title":"Transplantation"},{"key":"1121_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2337\/diacare.27.2.461","volume":"27","author":"Golberg","year":"2004","unstructured":"Golberg PA et al (2004) Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27:461\u2013467","journal-title":"Diabetes Care"},{"key":"1121_CR20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00007890-198601000-00008","volume":"41","author":"Hahn","year":"1986","unstructured":"Hahn HJ, Laube F, Lucke S, Kloting I, Kohnert KD, Warzock R (1986) Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats. Transplantation 41:44\u201347","journal-title":"Transplantation"},{"key":"1121_CR21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1034\/j.1600-6143.2003.00186.x","volume":"3","author":"Hathout","year":"2003","unstructured":"Hathout EH, Chinnock RE, Johnston JK et al (2003) Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant patients. Am J Transplant 3:994\u2013998","journal-title":"Am J Transplant"},{"key":"1121_CR22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/diacare.22.9.1408","volume":"22","author":"Hill Golden","year":"1999","unstructured":"Hill Golden S, Peart-Vigilance C, Kao WHL, Brancati FL (1999) Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes Diabetes Care 22:1408\u20131414","journal-title":"Diabetes Care"},{"key":"1121_CR23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2337\/diacare.18.6.870","volume":"18","author":"Hirsch","year":"1995","unstructured":"Hirsch IB et al (1995) Inpatient management of adults with diabetes. Diabetes Care 18:870\u2013878","journal-title":"Diabetes Care"},{"key":"1121_CR24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1056\/NEJMra040832","volume":"352","author":"Hirsch","year":"2005","unstructured":"Hirsch IB (2005) Drug Therapy: Insulin Analogues. N Engl J Med 352:174\u2013183","journal-title":"N Engl J Med"},{"key":"1121_CR25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","volume":"283","author":"Hjalmarson","year":"2000","unstructured":"Hjalmarson A et al (2000) (Merit-HF), Merit-HF study group. JAMA 283:1295\u20131302","journal-title":"JAMA"},{"key":"1121_CR26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","volume":"64","author":"Hjelmesaeth","year":"1997","unstructured":"Hjelmesaeth J, Hartmann A, Kofstad J et al (1997) Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 64:979","journal-title":"Transplantation"},{"key":"1121_CR27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","volume":"7","author":"Kasiske","year":"1996","unstructured":"Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MP, Ma JZ (1996) Cardiovascular Disease After Renal Transplantation. J Am Soc Nephrol 7:158\u2013165","journal-title":"J Am Soc Nephrol"},{"key":"1121_CR28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","volume":"3","author":"Kasiske","year":"2003","unstructured":"Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after transplantation in the United States. Am J Transplant 3:178","journal-title":"Am J Transplant"},{"key":"1121_CR29","first-page":"550","volume":"11","author":"Keogh","year":"1992","unstructured":"Keogh A, Macdonald P, Mundy J, Chang V, Harvison A, Spratt P (1992) Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation. J Heart Lung Transplant 11(3.1):550\u2013555","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR30","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","volume":"110","author":"Keogh","year":"2004","unstructured":"Keogh A, Richardson M, Ruygrok P, Spratt P, Galbraith A, O\u2019Driscoll G, Macdonald P, Esmore D, Muller D, Faddy S (2004) Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary heart disease at 2 years. A randomized clinical trial. Circulation. 110:2694\u20132700","journal-title":"Circulation"},{"key":"1121_CR31","first-page":"440","volume":"3","author":"Khwaja","year":"2003","unstructured":"Khwaja K, Asolati M, Harmon J et al (2003) 95% graft survival at 3 years posttransplant with steroid-free maintenance immunosuppression. Am J Transplant 3(Suppl 5):440","journal-title":"Am J Transplant"},{"key":"1121_CR32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bmj.318.7191.1104","volume":"318","author":"Knoll","year":"1999","unstructured":"Knoll GA, Bell RC (1999) Tacrolimus versus cyclosporine for immunosuppression in renal transplantation: meta-analysis of randomized trials. BMJ 318:1104","journal-title":"BMJ"},{"key":"1121_CR33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403","journal-title":"N Engl J Med"},{"key":"1121_CR34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","volume":"66","author":"Kobashigawa","year":"1998","unstructured":"Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, Costanzo M, Eisen H, Dureau G, Ratkovec R, Hummel M, Ipe D, Johnson J, Keogh A, Mamelok R, Mancini D, Smart F, Valantine H (1998) A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients: Mycophenolate Mofetil Investigators. Transplantation 66:507\u2013515","journal-title":"Transplantation"},{"key":"1121_CR35","first-page":"963","volume":"14","author":"Kobashigawa","year":"1995","unstructured":"Kobashigawa JA, Stevenson LW, Brownfield ED, Gleeson MP, Moriguchi JD, Kawata N, Minkley R, Drinkwater DC, Laks H (1995) Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits. J Heart Lung Transplant 14(5):963\u2013967","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00007890-199002000-00015","volume":"49","author":"Ladowski","year":"1990","unstructured":"Ladowski JS, Kormos RL, Uretsky BF, Griffith BF, Armitage JM, Hardesty RL (1990) Heart transplantation in diabetic recipients. Transplantation 49:303\u2013305","journal-title":"Transplantation"},{"key":"1121_CR37","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.CIR.0000121747.71054.79","volume":"109","author":"Lazar","year":"2004","unstructured":"Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS (2004) Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109(12):1497\u20131502","journal-title":"Circulation"},{"key":"1121_CR38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00007890-199509000-00008","volume":"60","author":"Lindholm","year":"1995","unstructured":"Lindholm A, Albrechtsen D, Frodin L, Persson NH, Lundgren G (1995) Ischemic heart disease-major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60:451\u2013457","journal-title":"Transplantation"},{"key":"1121_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0196-6553(99)70088-X","volume":"27","author":"Mangram","year":"1999","unstructured":"Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee (1999) Guideline for Prevention of Surgical Site Infection. Am J Infect Control 27(2):97\u2013132","journal-title":"Am J Infect Control"},{"key":"1121_CR40","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1053-2498(02)01219-6","volume":"22","author":"Marelli","year":"2003","unstructured":"Marelli D, Laks H, Patel B, Kermani R, Marmureanu A, Patel J, Kobashigawa J (2003) Heart Transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant 22:1091\u20131097","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR41","first-page":"782","volume":"17","author":"Meiser","year":"1998","unstructured":"Meiser BM, Uberfuhr P, Fuchs A et al (1998) Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant 17:782\u2013788","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR42","first-page":"431","volume":"11","author":"Miller","year":"1992","unstructured":"Miller LW, Wolford T, McBride LR, Peigh P, Pennington DG (1992) Successful withdrawal of corticosteroids in heart transplantation. J Heart Lung Transplant 11(2.2):431\u2013434","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.25.3.583","volume":"25","author":"Montori","year":"2002","unstructured":"Montori VM, Velosa JA, Basu A et al (2002) Posttransplantation diabetes. A systematic review of the literature. Diabetes Care 25:583\u2013592","journal-title":"Diabetes Care"},{"key":"1121_CR44","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.jtcvs.2003.11.063","volume":"127","author":"Morgan","year":"2004","unstructured":"Morgan JA, John R, Weinberg AD, Colletti NJ, Mancini DM, Edwards NM (2004) Heart transplantation in diabetic recipients: A decade review of 161 patients at Columbia Presbyterian. J Thorac Cardiovasc Surg 127:1486\u20131492","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1121_CR45","first-page":"943","volume":"11","author":"Munoz","year":"1992","unstructured":"Munoz E, Lonquist JL, Radovancevic B, Baldwin RT, Ford S, Duncan M et al (1992) Long-term results in diabetic patients undergoing heart transplantation. J Heart Lung Transplant 11(5):943\u2013949","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2337\/diab.35.9.1049","volume":"35","author":"Neilsen","year":"1986","unstructured":"Neilsen JH, Mandrup-Poulsen T, Nerup J (1986) Direct effects of cyclosporine A on human pancreatic betacells. Diabetes 35:1049\u20131052","journal-title":"Diabetes"},{"key":"1121_CR47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-199802270-00011","volume":"65","author":"Neylan","year":"1998","unstructured":"Neylan JF (1998) Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. Transplantation 65:515","journal-title":"Transplantation"},{"key":"1121_CR48","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diacare.24.9.1614","volume":"24","author":"Nichols","year":"2001","unstructured":"Nichols GA et al (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence and risk factors. Diabetes Care 24:1614\u20131619","journal-title":"Diabetes Care"},{"key":"1121_CR49","first-page":"III-111","volume":"80","author":"Olivari","year":"1989","unstructured":"Olivari MT, Homans DC, Wilson RF, Kubo SH, Ring WS (1989) Coronary artery disease in cardiac transplant patients receiving triple drug immunosuppressive therapy. Circulation 80 (suppl III):III-111\u2013III-115","journal-title":"Circulation"},{"key":"1121_CR50","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"OPTIME-CHF","year":"2002","unstructured":"OPTIME-CHF investigators (2002) JAMA 287:1541\u20131547","journal-title":"JAMA"},{"key":"1121_CR51","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","volume":"106","author":"Packer","year":"2002","unstructured":"Packer M et al (2002) Copernicus Study. Circulation 106:2194\u20132197","journal-title":"Circulation"},{"key":"1121_CR52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","volume":"20","author":"Pan","year":"1997","unstructured":"Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537\u2013544","journal-title":"Diabetes Care"},{"key":"1121_CR53","first-page":"764","volume":"111","author":"Pham","year":"1996","unstructured":"Pham SM, Kormos RL, Hattler BG et al (1996) A prospective trial of tacrolimus (FK506) in clinical heart transplantation. Cardiovasc Surg 111:764\u2013772","journal-title":"Cardiovasc Surg"},{"key":"1121_CR54","first-page":"775","volume":"117","author":"Reichart","year":"1998","unstructured":"Reichart B, Meiser B, Vigano M et al (1998) European multicentre tacrolimus (FK506) heart pilot study: one-year results\u2014European Tacrolimus Multicentre Heart Study Group. J Heart Lung Transplant 117:775","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR55","first-page":"356","volume":"7","author":"Rhenman","year":"1988","unstructured":"Rhenman MJ, Rhenman B, Icenogle T, Christensen R, Copeland J (1988) Diabetes and heart transplantation. J Heart Transplant 7:356\u2013358","journal-title":"J Heart Transplant"},{"key":"1121_CR56","first-page":"3164","volume":"23","author":"Rilo","year":"1991","unstructured":"Rilo HLR, Zeng Y, Alejandro R, Carroll PB, Bereiter D, Venkataramanan R, Tzakis AG, Starzl TE, Ricordi C (1991) Effect of FK506 on function of human islets of Langerhans. Transplant Proc 23:3164\u20133165","journal-title":"Transplant Proc"},{"key":"1121_CR57","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1034\/j.1600-6143.2003.00041.x","volume":"3","author":"Rostaing","year":"2003","unstructured":"Rostaing L, Catarovich D, Mourad G, Neumayer H H, Rigotti P, The CARMEN Study Group (2003) Steroid-free immunosuppression with a combination of daclizumab, tacrolimus and MMF is efficacious and safe: results of a large multicenter trial in renal transplantation. Am J Transplant 3 (Suppl 5):312","journal-title":"Am J Transplant"},{"key":"1121_CR58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1399-0012.1998.tb01013.x","volume":"12","author":"Sagedal","year":"1998","unstructured":"Sagedal S, Asberg A, Hartmann A, Bergan S, Berg KJ (1998) Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients. Clin Transplant 12(6):553\u2013556","journal-title":"Clin Transplant"},{"key":"1121_CR59","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.26.2.510","volume":"26","author":"Shah","year":"2003","unstructured":"Shah BR, Hux JE (2003) Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26(2):510\u2013513","journal-title":"Diabetes Care"},{"key":"1121_CR60","first-page":"814","volume":"27","author":"Shapiro","year":"1995","unstructured":"Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Fung JJ, McCauley J, Randhawa P, Demetris AJ, Irish W, Jain A, Mitchell S, Hakala TR, Simmons RL, Starzl TE (1995) A prospective, randomized trial of FK506\/prednisone vs FK506\/azathioprine\/prednisone in renal transplant patients. Transplant Proc 27:814\u2013817","journal-title":"Transplant Proc"},{"key":"1121_CR61","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/S0041-1345(97)00576-9","volume":"29","author":"Shapiro","year":"1997","unstructured":"Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Gritsch HA, McCauley J, Fung JJ, Hakala TR, Simmons RL, Sterzl TE (1997) Reversibility of tacrolimus-induced post-transplant diabetes: An illustrative case and review of the literature. Transplant Proc 29:2737\u20132738","journal-title":"Transplant Proc"},{"key":"1121_CR62","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1086\/421095","volume":"38","author":"Statement","year":"2004","unstructured":"Statement by the Surgical Infection Prevention Guideline Writers Workgroup (2004) Antimicrobial prophylaxis for surgery: An advisory statement from the national surgical infection prevention project. Clinical Infectious Diseases 38:1706\u20131715","journal-title":"Clinical Infectious Diseases"},{"key":"1121_CR63","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00007890-200105150-00001","volume":"71","author":"Steinman","year":"2001","unstructured":"Steinman TI, Becker BN, Frost AE, Olthoff KM, Smart FW, Suki WN et al (2001) Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation 71:1189\u20131204","journal-title":"Transplantation"},{"key":"1121_CR64","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0003-4975(02)03778-5","volume":"74","author":"Szabo","year":"2002","unstructured":"Szabo Z, Hakanson E, Svedjeholm R (2002) Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg 74(3):712\u2013719","journal-title":"Ann Thorac Surg"},{"key":"1121_CR65","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/00007890-199506000-00018","volume":"59","author":"Tamura","year":"1995","unstructured":"Tamura K, Fujimura T, Tsutsumi T, Nakamura K, Ogawa T, Atumaru C, Hirano Y, Ohara K, Ohtsuka K, Shimomura K, Kobayashi M (1995) Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic b-cell. Transplantation 59:1606\u20131613","journal-title":"Transplantation"},{"key":"1121_CR66","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","volume":"18","author":"Taylor","year":"1999","unstructured":"Taylor DO, Barr ML, Radovancevic B et al (1999) A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 18:336\u2013345","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR67","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.healun.2004.05.004","volume":"23","author":"Taylor","year":"2004","unstructured":"Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI (2004) The registry of the international society for heart and lung transplantation: Twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 23:796\u2013803","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR68","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.healun.2005.05.018","volume":"24","author":"Taylor","year":"2005","unstructured":"Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI (2005) The registry of the international society for heart and lung transplantation: Twenty-second official adult heart transplant report-2005 J Heart Lung Transplant 24:945\u2013982","journal-title":"J Heart Lung Transplant"},{"key":"1121_CR69","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0041-1345(02)02640-4","volume":"34","author":"Teebken","year":"2002","unstructured":"Teebken OE, Struber M, Harringer W et al (2002) Primary immunosuppression with tacrolimus and mycophenolate mofetil vs cyclosporine and azathioprine in heart transplant recipients. Transplant Proc 34:1265\u20131268","journal-title":"Transplant Proc"},{"key":"1121_CR70","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343\u20131350","journal-title":"N Engl J Med"},{"key":"1121_CR71","first-page":"3158","volume":"23","author":"Tze","year":"1991","unstructured":"Tze WJ, Tai J, Murase N, Tzakis A, Starzl TE (1991) Effect of FK506 on glucose metabolism and insulin secretion innormal rats. Transplant Proc 23:3158\u20133160","journal-title":"Transplant Proc"},{"key":"1121_CR72","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"Van Den Berghe","year":"2001","unstructured":"Van Den Berghe G et al (2001) Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 345:1359\u20131367","journal-title":"N Engl J Med"},{"key":"1121_CR73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","volume":"31","author":"Van Den Berghe","year":"2003","unstructured":"Van Den Berghe G et al (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359\u2013366","journal-title":"Crit Care Med"},{"key":"1121_CR74","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000054611.89228.92","volume":"107","author":"Vermes","year":"2003","unstructured":"Vermes E et al (2003) Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the studies of left ventricular dysfunction SOLVD. Circulation 107:1291","journal-title":"Circulation"},{"key":"1121_CR75","first-page":"1531","volume":"287","author":"VMAC","year":"2002","unstructured":"VMAC Investigators (2002) JAMA 287:1531\u20131540","journal-title":"JAMA"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-006-1121-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-006-1121-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-006-1121-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T09:20:48Z","timestamp":1736241648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-006-1121-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":75,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1007\/s00392-006-1121-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"type":"print","value":"1861-0684"},{"type":"electronic","value":"1861-0692"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}